Cite

HARVARD Citation

    Astbury, S. et al. (2022). HLA‐DR polymorphism in SARS‐CoV‐2 infection and susceptibility to symptomatic COVID‐19. Immunology. 166 (1), pp. 68-77. [Online]. 
  
Back to record